Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07104929 · ClinicalTrials.gov registry record · Phase 2
Beta Glucan 500 and Biological Age and Immune Age
A Phase 2 study, sponsored by OvationLab.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT07104929 is a Phase 2 study that has completed, run by OvationLab. The registered enrollment target is 60 participants.
The verdict
NCT07104929, a Phase 2 study, has completed, sponsored by OvationLab.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The primary purpose of this study is to evaluate the effects of BWH Labs - Beta Glucan 500 on biomarkers of biological and immune age among healthy adults. A single-arm, open-label prospective study will be conducted evaluating the impact of 12 weeks of supplementation with two capsules daily of Beta Glucan 500 on a variety of validated markers of biological and immune age on the comprehensive TruAge panel (TruDiagnostics, Lexington, KY).
Interventions
- DIETARY_SUPPLEMENT Beta Glucan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-05-14 |
| Est. Completion | 2025-10-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07104929
The ClinicalTrials.gov registry entry for NCT07104929 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OvationLab, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Beta Glucan is the first listed.
NCT07104929 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07104929 about?
NCT07104929 is a clinical study titled "Beta Glucan 500 and Biological Age and Immune Age". The primary purpose of this study is to evaluate the effects of BWH Labs - Beta Glucan 500 on biomarkers of biological and immune age among healthy adults. A single-arm, open-label prospective study will be conducted evaluating the impact of 12 weeks of supplementation with two capsules daily of Be...
What is the current status of trial NCT07104929?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2025-05-14. Estimated completion is 2025-10-09.
What interventions are being tested in trial NCT07104929?
The interventions under investigation include: Beta Glucan (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07104929?
This trial is sponsored by OvationLab, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.